Faraz Berjis
Berkeley, CANPI 1366553885
Payments from drug & device makers
$1,693in general payments, 2019–2025
Across 114 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$428
- Johnson & Johnson$340
- Takeda Pharmaceuticals U.S.A., Inc.$274
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$115
- Pfizer$101
- Medtronic$82
- plus $353 from 13 others
What the payments were for
- Food & beverage$1,693100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $428 |
| Johnson & Johnson | 28 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $274 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $115 |
| Pfizer | 5 | $101 |
| Medtronic | 1 | $82 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
| Shionogi Inc | 2 | $44 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Gilead | 2 | $33 |
| QOL Medical, LLC | 2 | $33 |
| Alfasigma USA, Inc. | 1 | $26 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Boston Scientific | 1 | $19 |
| UCB, Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Merck | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| CSL Behring | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.